Abstract
Interleukin-1 beta converting enzyme (ICE)-like proteases, which are synthesized as inactive precursors, play a key role in the induction of apoptosis. We now demonstrate that benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK), an ICE-like protease inhibitor, inhibits apoptosis by preventing the processing of CPP32 to its active form. These results suggest that novel inhibitors of apoptosis can be developed which prevent processing of proforms of ICE-like proteases.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amino Acid Chloromethyl Ketones / pharmacology*
-
Amino Acid Sequence
-
Apoptosis / drug effects*
-
Caspase 3
-
Caspases*
-
Cysteine Endopeptidases / drug effects*
-
Cysteine Endopeptidases / metabolism*
-
Cysteine Proteinase Inhibitors / pharmacology
-
Enzyme Activation / drug effects
-
Humans
-
Leukemia, Monocytic, Acute / enzymology
-
Leukemia, Monocytic, Acute / pathology
-
Leukemia, T-Cell / enzymology
-
Leukemia, T-Cell / pathology
-
Molecular Sequence Data
-
Oligopeptides / pharmacology
-
Poly(ADP-ribose) Polymerase Inhibitors
-
Poly(ADP-ribose) Polymerases / metabolism
-
Protease Inhibitors / pharmacology*
-
Tumor Cells, Cultured
Substances
-
Amino Acid Chloromethyl Ketones
-
Cysteine Proteinase Inhibitors
-
Oligopeptides
-
Poly(ADP-ribose) Polymerase Inhibitors
-
Protease Inhibitors
-
acetyl-aspartyl-glutamyl-valyl-aspartal
-
benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
-
Poly(ADP-ribose) Polymerases
-
CASP3 protein, human
-
Caspase 3
-
Caspases
-
Cysteine Endopeptidases